improve science, health and society
Welcome to the Helleday Laboratory
Our commitment does not stop with science at the basics; we bring our results all the way to the patients. The Helleday Laboratory focuses on harnessing defects in the DNA damage response and metabolism to develop novel therapies. The group is behind several success stories such as the synthetic lethal concept of treating BRCA mutated cancers with PARP inhibitors.